AI Tumor Clone Response Prediction for Combination Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Tumors evolve resistance mechanisms that make traditional therapies ineffective, necessitating a prediction model to identify combination therapies targeting multiple tumor clones.
Innovation Solution
A prediction model using artificial intelligence platforms and cell line perturbation data to rank responses to different perturbations, allowing for the development of combination therapies tailored to specific tumor clones.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional cancer therapies are used, then treatment simplicity is maintained, but tumor clones with resistance mechanisms evade elimination and cause disease progression
Solution Approach 1:
The AI platform performs preliminary analysis of tumor clone genetics and predicts optimal therapy combinations before treatment begins. By pre-calculating which therapy combinations will effectively target specific resistance mechanisms in a patient's tumor clones, the system enables proactive rather than reactive treatment planning, improving therapeutic effectiveness while managing complexity through computational preprocessing
Solution Approach 2:
The system changes the parameter of therapy selection from empirical guesswork to data-driven precision by analyzing genetic parameters of tumor clones and matching them with predicted responses to specific therapy combinations. This parameter transformation allows the system to navigate the complexity of multiple therapy options by evaluating them based on objective genetic markers and predicted efficacy metrics
2Reliability
If combination therapies targeting multiple resistance mechanisms are developed, then disease progression is prevented, but prediction accuracy of clone responses to perturbations is required
Solution Approach 1:
The system uses cell line data as copies or proxies for actual patient tumor clones. By training the AI platform on perturbation responses of cell lines that mimic human tumor genetics, the system creates a virtual model that can predict real clone responses without requiring direct experimentation on patient tissues. This copying approach enables high-precision prediction while avoiding the ethical and practical limitations of direct patient cell testing
Solution Approach 2:
The AI platform incorporates feedback loops where prediction results are continuously refined based on comparative analysis of multiple cell line responses. The system learns from patterns across numerous cell line perturbations and adjusts its predictions accordingly, improving measurement precision through iterative optimization and validation against known response patterns
3Extent of automation
If cell line perturbation data is used to train AI platform, then prediction capability is improved, but data compilation and processing time increases
Solution Approach 1:
The system performs preliminary data compilation and processing by pre-training the AI platform on extensive cell line perturbation data before actual patient prediction is needed. This upfront preparation creates a ready-to-use predictive model, so when real patient data arrives, the system can rapidly generate predictions without time-consuming data processing. The time investment is shifted from the critical prediction moment to the preparatory training phase
Solution Approach 2:
The system efficiently processes and discards irrelevant features from the compiled cell line data, retaining only the most predictive patterns and relationships. By filtering out redundant information during training and focusing on key predictive signals, the system reduces the effective data processing burden while maintaining prediction accuracy, thus minimizing time loss during actual use
Data Source
AI summary
An AI platform is used for developing a combination therapy for a patient afflicted with a tumor that has produced clones. The combination therapy, which includes at least two perturbations, is capable of targeting clones (including subclones) that have escaped therapeutic intervention due to resistance and/or evolution. The AI platform is trained with perturbation data obtained from at least one cell line that has similar characteristics to a clone of interest. The trained AI platform predicts how the clone of interest will respond to perturbations and ranks the perturbation responses from highest to lowest. The at least one cell line may be an existing cell line from a well-established database or a synthetic cell line generated by the AI platform. The AI platform may include one or more of a machine learning platform, a deep learning platform, an artificial neural network (ANN), a convolution neural network (CNN), and a generative adversarial network (GAN).